ACE/LYMPHOCYTE RATIO AND CONUT SCORE: KEY PREDICTORS OF EXTRAPULMONARY INVOLVEMENT AND RECURRENCE IN SARCOIDOSIS

被引：0

作者：

Canoglu, Kadir ^{[1
]}

Ayten, Omer ^{[2
]}

Kulah, Gokce ^{[3
]}

Avci, Hasan Furkan ^{[4
]}

Kocabag, Ilyas ^{[1
]}

Ogur, Erhan ^{[1
]}

Iscanli, Insa Gul Ekiz ^{[5
]}

机构：

[1] Abdulhamid Han Training & Res Hosp, Pulmonol, Istanbul, Turkiye

[2] Liv Vadi Istanbul Hosp, Pulmonol, Istanbul, Turkiye

[3] Umraniye Training & Res Hosp, Pathol, Istanbul, Turkiye

[4] Sureyyapasa Chest Dis & Thorac Surg Training & Res, Immunol & Allergy, Istanbul, Turkiye

[5] Sureyyapasa Chest Dis & Thorac Surg Training & Res, Resp Intens Care Unit, Istanbul, Turkiye

来源：

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 2025年 / 42卷 / 01期

关键词：

ace/lymphocyte ratio; conut score; extrapulmonary sarcoidosis; recurrence predictors; angiotensin converting enzyme; nutritional status; sarcoidosis outcomes; disease recurrence;

D O I：

10.36141/svdld.v42i1.15564

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Background and aim: Extrapulmonary involvement is associated with high morbidity and mortality in sarcoidosis. Sarcoidosis recurrence rates vary between 37-75% in the literature. In this study, we aimed to investigate the association of ACE/lymphocyte ratio and The Controlling Nutritional Status (CONUT) score with systemic involvement and recurrence in sarcoidosis. Methods: 156 adult patients diagnosed with sarcoidosis was conducted in this retrospective, single-center study between 01.09.2016- 31.12.2021 in the pulmonology clinic of Sultan 2. Abdulhamid Han Training and Research Hospital in Istanbul/T & uuml;rkiye. The ACE/lymphocyte ratio was calculated by dividing the serum ACE level by lymphocyte count. CONUT score was calculated according to serum albumin, lymphocyte count and total cholesterol levels. Results: Fifty (32%) patients had systemic involvement. In patients with systemic involvement, serum ACE and ACE/lymphocyte ratio were higher and lymphocytes were lower than those without systemic involvement (p<0.05). 24 (15.4%) patients had recurrence. Serum ACE and ACE/lymphocyte ratio were found to be higher in patients with recurrence compared to those without recurrence (p<0.05). There was no statistically significant difference between the groups in terms of CONUT score (p=0.232). In Spearmen's Rho correlation, systemic involvement and recurrence were positively correlated with ACE/lymphocyte ratio (p<0.05). In Binary Logistic Regression, ACE/lymphocyte ratio was not associated with recurrence and systemic involvement (p>0.05). In ROC curve analysis, the sensitivity, specificity and AUC of ACE/lymphocyte ratio in predicting systemic involvement were 78%, 39.8% and 0.644, respectively with a cut-off value of 19.55; and in predicting recurrence were 79.2%, 44.8% and 0.714, respectively with a cut-off value of 22.41. Conclusions: The ACE/lymphocyte ratio, which was evaluated for the first time in the literature, was found to be higher in patients with systemic involvement in sarcoidosis than in those without, and higher in patients with recurrence than in those without. Therefore, it can be used to predict extrapulmonary involvement, which can have high mortality and morbidity, as well as recurrence in post-treatment follow-up.

引用

页数：5